Discover Alaska's borealpox virus, formerly Alaskapox, now named for its ecosystem origins. Learn about this orthopoxvirus affecting humans and small mammals, with prevention insights.
A red-backed vole
(Adobe Stock 284886779 by David)
The Alaska Department of Health, in collaboration with the CDC and the World Health Organization, has officially renamed the Alaskapox virus to the borealpox virus as of April 2024. This update also includes changing the name of the corresponding disease from Alaskapox to borealpox.
The new name was chosen to reflect the virus's initial identification in the boreal ecosystem, which includes both humans and small mammal reservoirs. The name borealpox is more general and less specific than the previous name, which allows for the possibility of identifying the virus in small mammals and humans outside of Alaska's borders and into Canada and other areas.
Alaska Public Media (NPR) wrote that in a presentation at the Alaska Tribal Conference on Environmental Management held in Anchorage, Katherine Newell, PhD, MPH, a US CDC epidemiology field officer who works at the Alaska Department of Health, and spoke at a conference hosted by the Alaska Native Tribal Health Consortium, announcing the name change. “We are changing the name of Alaskapox virus to borealpox virus, which is what it will now be known as from now on.”
Borealpox virus, an orthopoxvirus, first emerged when a patient in Fairbanks, Alaska, was diagnosed with the disease in 2015. Orthopoxviruses are recognized to infect various mammals, including humans, often resulting in the development of skin lesions. Since its initial detection, 6 additional borealpox virus cases have been reported in Alaska, with 5 occurring among people residing in the Fairbanks North Star Borough and one case in the Kenai Peninsula Borough.
Although current data suggests that borealpox virus is mainly present among small mammals such as red-backed voles and shrews in the Fairbanks North Star Borough, it is possible that the virus is more prevalent in small mammal populations throughout Alaska. In addition, there may be cases of human infections that remain undiagnosed. The experts are also considering the potential role of domestic pets, such as cats and dogs, in transmitting the virus. The one death was from an immunocompromised individual who had been feeding a stray cat.
To date, no documented cases of human-to-human transmission of borealpox virus have been identified. However, given that certain orthopoxviruses can spread through direct contact with skin lesions, it is advised that individuals with skin lesions suspected to be caused by borealpox virus keep the affected area covered with a bandage to minimize potential transmission.
Among the small mammal species in Alaska, the northern red-backed vole stands out as one showing evidence of harboring the borealpox virus. Symptoms associated with borealpox infection typically include the presence of 1 or more skin lesions characterized by bumps or pustules. Additional symptoms may include swollen lymph nodes and joint and muscle pain. It is essential to note that immunocompromised individuals may face a heightened risk of experiencing more severe illness if infected with the borealpox virus.
According to the Infectious Diseases Society of America, the northern red-backed vole has a vast geographic range that extends across Alaska, parts of Canada, Russia, China, and Scandinavia. It won't be surprising if different borealpox viruses are found in patients and animal species in other regions of Alaska and other countries. Therefore, active epidemiologic surveillance and testing for susceptibility to antiviral drugs and vaccines available for mpox and smallpox in the US Strategic National Stockpile are required.
Vigilance in monitoring and understanding the virus's spread among both wildlife and human populations remains crucial for effective disease management and prevention strategies. The Alaska Department of Health continues to collaborate closely with health organizations to track the virus's progression and provide guidance to safeguard public health in the region.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.